FDA Drug Recalls

Recalls / Class II

Class IID-665-2013

Product

Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

Affected lot / code info
Lot number CABCBFBA:15, Exp date: 4/13/2013; Lot number CABCACBA:58, Exp date: 3/31/2013; Lot number CABCAHBB:54, Exp date: 5/6/2013; Lot number CABCCHBB:63, Exp date: 5/26/2013; Lot number CABCAFBC:31, Exp date: 6/3/2013; Lot number CABCCHBS:23, Exp date: 6/25/2013; Lot number CABDBAAB:64, Exp date: 7/9/2013; Lot number CABDAIAB:59, Exp date: 7/7/2013; Lot number CABDAFAC:48, Exp date: 8/4/2013; Lot number CABDBJAC:27, Exp date: 8/18/2013 and Lot number CABDABAD:61, Exp date: 8/28/2013.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Recalling firm

Firm
Clinical Specialties Compounding Pharmacy
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
318 Baston Rd, N/A, Augusta, Georgia 30907

Distribution

Quantity
219ml total
Distribution pattern
FL, GA and SC.

Timeline

Recall initiated
2013-03-20
FDA classified
2013-07-03
Posted by FDA
2013-07-10
Terminated
2017-02-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-665-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls